The Valley Desk

ArticleThe Journal of clinical investigationPublished

Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Temple Health, Thomas Jefferson University, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
The Journal of clinical investigation
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Melanoma; Skin Neoplasms; Neoplasm Invasiveness; Proto-Oncogene Proteins B-raf; Neoplasm Proteins; Protein Kinase Inhibitors; Xenograft Model Antitumor Assays; Mutation
PubMed ID
40955663
PubMed Central ID
PMC12435839
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal